Vascular endothelial growth factor enhances venous thrombus recanalisation and organisation

Thrombosis and Haemostasis

Volumn 89, Issue 1, 2003, Pages 169-176

  Waltham, Matthew ^a   Burnand, Kevin G ^a   Collins, Michael ^a   McGuinness, Catherine L ^a   Singh, Inderjit ^a   Smith, Alberto ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Angiogenesis; Recanalisation; Thrombus resolution; VEGF

Indexed keywords

IODINE 125; RECOMBINANT VASCULOTROPIN; VASCULOTROPIN;

ANALYTICAL ERROR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAVA VEIN DISEASE; CELL MIGRATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INDICATION; IMAGE ANALYSIS; INFERIOR CAVA VEIN; ISOTOPE LABELING; MALE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RECANALIZATION; STATISTICAL SIGNIFICANCE; VEIN THROMBOSIS;

EID: 0037250430     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613556     Document Type: Article

References (44)

1. Payling Wright H, Kubik MM, Hayden M. Influence of anticoagulant administration on the rate of recanalisation of experimentally thrombosed veins. Br J Surg 1952; 40: 163-6.
2. Killewich LA, Bedford GR, Beach KW, Strandness DE, Jr. Spontaneous lysis of deep venous thrombi: Rate and outcome. J Vasc Surg 1989; 9: 89-97.
3. Van Ramshorst B, Van Bemmelen PS, Hoeneveld H, Faber JA, Eikelboom BC. Thrombus regression in deep venous thrombosis. Quantification of spontaneous thrombolysis with duplex scanning. Circulation 1992; 86: 414-9.
4. Franzeck UK, Schalch I, Bollinger A. On the relationship between changes in the deep veins evaluated by duplex somography and the postthrombotic syndrome 12 years after deep vein thrombosis. Thromb Haemost 1997; 77: 1109-12.
5. Meissner MH, Manzo RA, Bergelin RO, Markel A, Strandness DE, Jr. Deep venous insufficiency: The relationship between lysis and subsequent reflux. J Vasc Surg 1993; 18: 596-605.
6. O'Shaughnessy AM, Fitzgerald DE. Natural history of proximal deep vein thrombosis assessed by duplex ultrasound. Int Angiol 1997; 16: 45-9.
7. Meissner MH, Caps MT, Zierler BK, Polissar N, Bergelin RO, Manzo RA, Strandness DE, Jr. Determinants of chronic venous disease after acute deep venous thrombosis. J Vasc Surg 1998; 28: 826-33.
8. Wakefield TW. Treatment options for venous thrombosis. [Review]. J Vasc Surg 2000; 31: 613-20.
9. Armon MP, Hopkinson BR. Thrombolysis for acute deep vein thrombosis. Br J Surg 1996; 83: 580-1.
10. Wakefield TW, Linn MJ, Henke PK, Kadell AM, Wilke CA, Wrobleski SK, Sarkar M, Burdick MD, Myers DD, Strieter RM. Neovascularization during venous thrombosis organization: A preliminary study. J Vasc Surg 1999; 30: 885-92.
11. Virchow RR. Cellular Pathology. 1860.
12. Burnand KG, Gaffney PJ, McGuinness CL, Humphries J, Quarmby JW, and Smith A. The role of the monocyte in the generation and dissolution of arterial and venous thrombi. [Review]. Cardiovasc Surg 1998; 6: 119-25.
13. McGuinness CL, Humphries J, Waltham M, Burnand KG, Collins M, Smith A. Recruitment of labelled monocytes by experimental venous thrombi. Thromb Haemost 2001; 85: 1018-24.
14. Cox JST. The maturation and canalization of thrombi. Surg Gynecol Obstet 1963; 116: 593-9.
15. Sevitt S. Organic canalisation and vascularisation of deep vein thrombi studied with dyed-micropaque injected at necropsy. J Pathol 1970; 100: i.
16. Humphries J, McGuinness CL, Smith A, Waltham M, Poston R, Burnand KG. Monocyte chemotactic protein-1 (MCP-1) accelerates the organization and resolution of venous thrombi. J Vasc Surg 1999; 30: 894-9.
17. Ferrara N, Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 1999; 5: 1359-64.
18. Folkman J. Therapeutic angiogenesis in ischemic limbs. Circulation 1998; 97: 1108-10.
19. Folkman J. Angiogeneic therapy of the human heart. Circulation 1998; 97: 628-9.
20. Leung DW, Chachianes G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306-9.
21. Neufeld G, Cohen T, Gengrinovich S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999; 13: 9-22.
22. Waltham M, Burnand KG, Collins M, Smith A. Vascular endothelial growth factor and basic fibroblast growth factor are found in resolving venous thrombi. J Vasc Surg 2000; 32: 988-96.
23. McGuinness CL, Humphries J, Smith A, Burnand KG. A new model of venous thrombosis. Cardiovasc Surg 1997; 5: 123.
24. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161: 851-8.
25. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989; 246: 1309-12.
26. Connolly DT, Olander JV, Heuvelman D, Nelson R, Monsell R, Siegel N, Haymore BL, Leimgruber R, Feder J. Human vascular permeability factor. Isolation from U937 cells. J Biol Chem 1989; 264: 20017-24.
27. Pepper MS, Ferrara N, Orci L, Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 1992; 189: 824-31.
28. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marme D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 1996; 87: 3336-43.
29. Hobson MI. Increased vascularisation enhances axonal regeneration within an acellular nerve conduit. Ann R Coll Surg Engl 2002; 84: 47-53.
30. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, Ferrara N, Symes JF, Isner JM. Therapeutic angiogenesis. A sinle intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 1994; 93: 662-70.
31. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM. Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vasc Surg 1995; 21: 314-24.
32. Folkman J, Klagsburn M, Sasse J, Wadzinski M, Ingber D, Vlodavsky I. A heparin-binding angiogenic protein - Basic fibroblast growth factor - Is stored within basement membrane. Am J Pathol 1988; 130: 393-400.
33. Sahni A, Francis CW. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 2000; 96: 3772-8.
34. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 1992; 267: 26031-7.
35. Barleon B, Siemeister G, Martiny-Baron G, Weindel K, Herzog C, Marme D. Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells. Cancer Res 1997; 57: 5421-5.
36. Pepper MS, Ferrara N, Orci L, Montesano R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 1991; 181: 902-6.
37. Northeast AD, Soo KS, Bobrow LG, Gaffney PJ, Burnand KG. The tissue plasminogen activator and urokinase response in vivo during natural resolution of venous thrombus. J Vasc Surg 1995; 22: 573-9.
38. Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V, Ferrara N. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 1998; 273: 30336-43.
39. Asahara T, Murohara T, Sullivan A, Silver M, Van Der ZR, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-7.
40. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial pregenitor cells. EMBO J 1999; 18: 3964-72.
41. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999; 85: 221-8.
42. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219: 983-5.
43. Soo KS, Northeast AD, Happerfield LC, Burnand KG, Bobrow LG. Tissue plasminogen activator production by monocytes in venous thrombolysis. J Pathol 1996; 178: 190-4.
44. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan YC, Olander JV, Connolly DT, Stern D. Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte pro-coagulant activity, and promotes monocyte migration. J Exp Med 1990; 172: 1535-45.